$ZYXIQ News

Zynex Poised for New Future with Resolution of Federal Investigation

New Zynex Leadership Responds to Indictment of Former Executives

Zynex Inc (ZYXI) Q3 2025 Earnings Call Highlights: Navigating Financial Challenges Amid ...

Zynex, Inc. (ZYXI) Q3 2025 Earnings Call Prepared Remarks Transcript

Zynex Reports Third Quarter 2025 Financial Results

Zynex announces series of strategic initiatives, to evaluate alternatives

Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee

Zynex Sets Third Quarter 2025 Earnings Call

Global Women’s Health Rehabilitation Products Market Size/Share Worth USD 9.8 Billion by 2034 at a 6.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles

Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates

Zynex, Inc. (ZYXI) Q2 2025 Earnings Call Transcript

Zynex Reports Second Quarter 2025 Financial Results

Zynex Sets Second Quarter 2025 Earnings Call

Tricare Temporary Payment Suspension Update

Zynex Announces Steven Dyson as New CEO

Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis

Here’s Why Zynex (ZYXI) Fell in Q1

Zynex announces submission of 510(k) application for laser pulse oximeter

Zynex Submits FDA Application for Its NiCO Laser Pulse Oximeter